Stock Option Grant to Director Emer Leahy of Pasithea Therapeutics Corp.

On October 24, 2025, Pasithea Therapeutics Corp. granted 42,913 stock options to its director, Emer Leahy, under the company's 2023 Stock Incentive Plan. The options, which are exercisable at $0.715 per share, vest fully on the one-year anniversary of the grant date, provided that Dr. Leahy remains a director through that date. In the event of a Change in Control as defined in the Plan, the options will vest immediately. The options expire on October 23, 2035. This transaction is reported in accordance with Section 16 of the Securities Exchange Act of 1934.